CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.
Founded in 2009 in Tübingen, Germany, the company combines stateof-the-art sequencing technology with medical expertise – with the aim of identifying the genetic causes of diseases and supporting patient care. For researchers and pharmaceutical companies, CeGaT offers a broad portfolio of sequencing services and tumor analysis. CeGaT generates the data basis for clinical studies and medical innovations and drives science forward with its own insights.
The owner-managed company stands for independence, comprehensive personal customer service, and outstanding quality. CeGaT‘s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO 17025, and thus meets the highest international standards. In order to obtain first-class results, all processes are carried out in-house under scientific supervision.